Synthesis and in vitro antitumor activity of 1,3,4-oxadiazole derivatives based on benzisoselenazolone

Chemical and Pharmaceutical Bulletin

Volumn 60, Issue 7, 2012, Pages 887-891

  Luo, Zhen Hua ^a   He, Shuang Yan ^a   Chen, Bao Quan ^a   Shi, Yan Ping ^a   Liu, Yu Ming ^a   Li, Cai Wen ^a   Wang, Qiu Sheng ^a  

^a TIANJIN UNIVERSITY OF TECHNOLOGY   (China)

Author keywords

1,3,4 oxadiazole; Antitumor activity; Benzisoselenazolone; Synthesis

Indexed keywords

1,3,4 OXADIAZOLE DERIVATIVE; 2 (2 PHENYL 1,3,4 THIADIAZOL 5 YL)BENZISOSELENAZOL 3(2H)ONE; 2 [2 (2 FLUOROPHENYL) 1,3,4 THIADIAZOL 5 YL]BENZISOSELENAZOL 3(2H)ONE; 2 [2 (3,4,5 TRIMETHOXYPHENYL) 1,3,4 THIADIAZOL 5 YL]BENZISOSELENAZOL 3(2H)ONE; 2 [2 (4 BROMOPHENYL) 1,3,4 THIADIAZOL 5 YL]BENZISOSELENAZOL 3(2H)ONE; 2 [2 (4 CHLOROPHENYL) 1,3,4 THIADIAZOL 5 YL]BENZISOSELENAZOL 3(2H)ONE; 2 [2 (4 FLUOROPHENYL) 1,3,4 THIADIAZOL 5 YL]BENZISOSELENAZOL 3(2H)ONE; 2 [2 (4 ISOPROPYLPHENYL) 1,3,4 THIADIAZOL 5 YL]BENZISOSELENAZOL 3(2H)ONE; 2 [2 (4 METHOXYPHENYL) 1,3,4 THIADIAZOL 5 YL]BENZISOSELENAZOL 3(2H)ONE; 2 [2 (4 METHYLPHENYL) 1,3,4 THIADIAZOL 5 YL]BENZISOSELENAZOL 3(2H)ONE; 2 [2 (4 NITROPHENYL) 1,3,4 THIADIAZOL 5 YL]BENZISOSELENAZOL 3(2H)ONE; ANTINEOPLASTIC AGENT; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; DRUG SYNTHESIS; HUMAN; HUMAN CELL; IN VITRO STUDY; LIVER CANCER; LUNG CANCER;

EID: 84863544875     PISSN: 00092363     EISSN: 13475223     Source Type: Journal    
DOI: 10.1248/cpb.c12-00250     Document Type: Article

References (16)

1. Mantovani G., Maceiò A., Madeddu C., Serpe R., Massa E., Gramignano G., Lusso M. R., Curreli N., Rinaldi A., J. Exp. Ther. Oncol., 4, 69-78 (2004).
2. Wood S. M., Beckhaml C., Yosioka A., Darban H., Watson R. R., Integr. Med., 2, 85-92 (2000).
3. Fu J.-N., Wang J.-Y., Wang L.-H., Wang L., Tang W.-C., Cai G. X., Liu M., Zeng H.-H., J. Chin. Pharm. Sci., 19, 163-168 (2010).
4. El-Bayoumy K., Drugs Future, 22, 539-545 (1997).
5. Parnham M. J., Leyck S., Graf E., Dowling E. J., Blake D. R., Agents Actions, 32, 4-9 (1991).
6. Zhou Z. B., Xia X. P., Xu H. B., Zhao C. X., Chen C. Y., Chem. J. Chin. Univ., 14, 220-222 (1993).
7. Reich H. J., Jasperse C. P., J. Am. Chem. Soc., 109, 5549-5551 (1987).
8. Chen J., Xu R.-Q., Song B.-A., Jin L.-H., Hu D.-Y., Yang S., Zhang G.-P., Chin. J. Org. Chem., 26, 1418-1423 (2006).
9. Jain N., Pathak D. P., Mishra P., Jain S., J. Iran. Chem. Soc., 6, 77-81 (2009).
10. Amir M., Saifullah K., Akhter W., Indian J. Chem., 50B, 1107-1111 (2011).
11. Zarghi A., Tabatabai S. A., Faizi M., Ahadian A., Navabi P., Zanganeh V., Shafiee A., Bioorg Med. Chem. Lett., 15, 1863-1865 (2005).
12. Shi Y.-P, Chen B.-Q., Ma J., Liu Y.-M., Li C.-W., Acta Chim. Sin., 69, 2561-2566 (2011).
13. Han X..-L., Li H. P., Ma X.-J., Chen J.-Y., Chin. J. Pharmaceuticals, 35, 391-392 (2004).
14. Gibson M. S., Tetrahedron, 18, 1377-1380 (1962).
15. Scott F.L., Lambe T. M., Butler R. N., J. Chem. Soc., Perkin Trans. I, 1972, 1918-1923 (1972).
16. Srivastava M., Sing D., Kushwah A. S., Gokulan P. D., J. Current Pharm. Res., 4, 20-24 (2010).